DIN 02540053 — TAFINLAR 10 MG
TAFINLAR is a tablet for suspension of Dabrafenib marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Dabrafenib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02540053
- Brand name
- TAFINLAR
- Active ingredient
- Dabrafenib
- Strength
- 10 MG
- Dosage form
- TABLET FOR SUSPENSION
- Route
- ORAL
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- BRAF kinase inhibitor (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Dabrafenib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02409607 | TAFINLAR | 50 MG | CAPSULE | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |
| 02409615 | TAFINLAR | 75 MG | CAPSULE | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |